GH secretagogues
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults
Teichman SL, Neale A, Lawrence B, et al. · J Clin Endocrinol Metab · 2006
PMID: 16352683 · DOI: 10.1210/jc.2005-1536
Summary
Two randomized, double-blind, placebo-controlled, ascending-dose trials (28 and 49 days) in healthy adults aged 21-61. Endpoints: plasma GH and IGF-I time-course, half-life estimation, tolerability.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
Guides covering this compound
- CJC-1295 with DAC — the other molecule, and how to tell them apartThe DAC form is 279 daltons heavier than the no-DAC form and has its own CAS. One number on the COA separates them.2 min read
- Sermorelin — GHRH (1-29) and the peptide family built on itSermorelin is the unmodified first 29 residues of growth hormone releasing hormone. Every GHRH analog in this market is a modification of it.2 min read
- White label, private label, contract manufacturing — the differenceThree terms used interchangeably that mean different things commercially. Which one you actually want depends on who owns the formulation and who carries the inventory.3 min read
- Choosing a US peptide supplier — what separates themWhat separates suppliers when everyone's website says the same thing: where the material is made, who tests it, and what they will put in writing.5 min read
More GH secretagogues citations
- Ipamorelin, the first selective growth hormone secretagogueEur J Endocrinol · 1998
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in ratsGrowth Horm IGF Res · 1999
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analogJ Clin Endocrinol Metab · 2006